CN1060347C - Capsule for eliminating pathogenic factor and alleviating pain - Google Patents
Capsule for eliminating pathogenic factor and alleviating pain Download PDFInfo
- Publication number
- CN1060347C CN1060347C CN94115964A CN94115964A CN1060347C CN 1060347 C CN1060347 C CN 1060347C CN 94115964 A CN94115964 A CN 94115964A CN 94115964 A CN94115964 A CN 94115964A CN 1060347 C CN1060347 C CN 1060347C
- Authority
- CN
- China
- Prior art keywords
- present
- capsule
- alleviating pain
- treatment
- trigeminal neuralgia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a capsule for eliminating evils and alleviating pain, which is Chinese patent medicine prepared from Chinese angelica, cow-bezoar, manchurian wildginger, long pepper, fineleaf schizonepeta herb, common carpesium fruit, pericarpium zanthoxyli, ledebouriella root, hemlock parsley, scrophularia, largetrifoliolious bugbane rhizome, etc. The present invention has obvious curative effects of treating trigeminal neuralgia and also has the efficiency of alleviating pain, relieving spasms and promoting blood circulation to remove blood stasis, and the symptom of trigeminal neuralgia can be relieved in a short period. The present invention has the advantages of rapid effect taking, simplicity, convenience, easy realization, short treatment course, etc. The effective rate of the present invention is 90% according to clinic statistics, and the therapeutic effect of the present invention is stable according to observation for 1 to 3 years; cured patients nearly have no relapse phenomena.
Description
The present invention relates to the prosopalgic Chinese patent medicine of a kind of treatment.
The prosopalgic measure of known treatment has operative therapy and Western medicine analgesic carbamazepine etc., but side effect is many and easily recurrence, does not have the radical cure effect.Traditional Chinese medical science acupuncture commonly used and block therapy pain relieving, but general curative effect is of short duration, difficult as long-term or radical cure treatment means.
In traditional Chinese medical science works,, only in Chinese traditional treatment gout or prosopodynia, find similar description to the unspecial record of treatment trigeminal neuralgia.As putting down in writing in " Zhang Shi doctor logical " book: " prosopodynia ... can not the opening speech, hands touches i.e. pain, this is that positive yin channel network is subjected to pathogenic wind toxic, successor's meridians, blood clotting is stagnant and not all right." traditional Chinese medical science thinks that prosopodynia is many stagnant relevant with the rheumatism stasis of blood, so the rule of treatment is used dispelling wind and removing obstruction in the collateral more, methods such as heat clearing and blood stasis dispersing or liver-smoothing, qi-regulating.Though certain curative effect is arranged, specific aim is poor, and is still undesirable to treatment trigeminal neuralgia curative effect.
The purpose of this invention is to provide a kind of method and treat prosopalgic capsule for eliminating pathogenic factor and alleviating pain Chinese patent medicine with promoting blood circulation by removing wind, suppressing the hyperactive liver the kidney warming, blood-activating analgetic.
For achieving the above object, the main medicine of capsule for eliminating pathogenic factor and alleviating pain consists of Radix Angelicae Sinensis, Calculus Bovis, Herba Asari, Fructus Piperis Longi, Herba Schizonepetae, Fructus Carpesii, Pericarpium Zanthoxyli, Radix Saposhnikoviae, Rhizoma Chuanxiong, Radix Scrophulariae, Rhizoma Cimicifugae etc.; Wherein Radix Angelicae Sinensis and Calculus Bovis, Herba Asari, Fructus Piperis Longi, the weight ratio of Pericarpium Zanthoxyli is 1～1.2: 0.60～0.75: 0.13～0.33: 0.8～1.0: 0.7～0.9; Fructus Piperis Longi and Herba Schizonepetae, Fructus Carpesii, Pericarpium Zanthoxyli, Radix Saposhnikoviae, Rhizoma Chuanxiong, Radix Scrophulariae, the weight ratio of Rhizoma Cimicifugae is 1: 1, the above-mentioned Chinese medicine of respectively distinguishing the flavor of is cleaned dried, and screens out impurity, pulverization is with smalls Co
60The illumination-based disinfection sterilization, in the capsule of glue of packing into, every capsules includes Chinese medicine powder 0.4～0.5 gram, promptly gets the capsule for eliminating pathogenic factor and alleviating pain Chinese patent medicine.
The instructions of taking of this Chinese patent medicine is, looks trigeminal neuralgia patient course of disease length and physical condition, takes each oral 10～14 every day 2～3 times.Taking ten days is a course of treatment.Finish back drug withdrawal two days first course of treatment, continues to take a course of treatment.Can obtain recovery from illness general two courses of treatment, and indivedual persons take three courses of treatment at most and then can fully recover.
Reasonable recipe of the present invention, wherein, the Radix Angelicae Sinensis blood circulation promoting and blood stasis dispelling, Calculus Bovis heat clearing away poison, endogenous wind stopping relieves the pain; Herba Asari is ideal pain relieving good medicine, the Fructus Piperis Longi warming middle-JIAO to relieve pain; Pericarpium Zanthoxyli is controlled insufficiency of the spleen pain; Evil poison is dispersed in the feasible convulsion pain relieving of Radix Saposhnikoviae, Herba Schizonepetae, and Fructus Carpesii is a toil class medicine, and the blood stasis dispelling effect is arranged; The Rhizoma Chuanxiong blood circulation promoting and blood stasis dispelling, the Radix Scrophulariae nourishing YIN and supplementing the kidney, heat-clearing and toxic substances removing, Rhizoma Cimicifugae have the yang invigorating disperse function.Because of a little, to trigeminal neuralgia pain relieving spasmolytic targetedly, the eliminating evil effect of invigorating blood circulation, can alleviate prosopalgic symptom in a short time, have instant effect, simple and easy to do, advantages such as short treating period, more domestic at present tcm therapy is remarkably productive, has the treating both the principal and secondary aspects of a disease effect, clinical statistics 100 examples, effective percentage reaches 90%, and through observation in 1～3 year, efficacy consolidation, healing person does not have rebound phenomenon more substantially.
100 routine trigeminal neuralgia patient curative effect statistical tables
| Curative effect case number disease time | Alleviate fully (people) | Alleviate (people) | Invalid (people) | Patient's number (people) |
| Below 1 year | 4 | 2 | 2 | 8 |
| 2 years to 3 years | 22 | 23 | 2 | 56 |
| More than 3 years | 14 | 20 | 2 | 36 |
| Curative effect statistics (%) | 40 | 50 | 10 | 100 |
Among the 100 routine trigeminal neuralgia patients, male 46 people, women 54 people; 30～40 years old 12 age people, 40～50 years old 44 people, 50～60 years old 26 people, 18 people more than 60 years old, most patient age is 40～60 years old.Among the 100 routine patients, all make a definite diagnosis before going to a doctor at various big hospital inside and outside the province, and undesirable through various Chinese and western medicine medicine multi-treatment effects, still continue outbreak, wherein 8 routine patients once did the nerve block operation, and radical cure yet.Among the 100 routine patients, be and treat an above patient course of treatment, the person that after treating 1～2 time, no longer do not go to a doctor, curative effect can't the not routine people's scope of statistics of judgement person.Curative effect judging standard is: after alleviation was oral Chinese patent medicine of the present invention fully, pain stopped in two courses of treatment, observes three months not recidivists.Alleviation is to take medicine after two courses of treatment, and pain alleviates to some extent or prolong the interval of showing effect to some extent, but the general operate as normal of patient and give birth to the reviver.Invalid is that symptom does not have the changer substantially before and after taking medicine.
The present invention does not all find adverse side effect after the patient takes surplus in the of 20,000, safe and reliable.
Embodiments of the invention are; the consumption prescription of two courses of treatment is: Radix Angelicae Sinensis 15～18g, Calculus Bovis 1～10g, Herba Asari 2～5g, Fructus Piperis Longi 12～14g, Herba Schizonepetae 12～14g, Fructus Carpesii 12～14g, Pericarpium Zanthoxyli 10～12g, Radix Saposhnikoviae 12～14g, Rhizoma Chuanxiong 12～14g, Radix Scrophulariae 12～14g, Rhizoma Cimicifugae 12～14g.
Claims (1)
1, the prosopalgic capsule for eliminating pathogenic factor and alleviating pain of a kind of treatment; it is characterized in that medicament composing prescription is: Radix Angelicae Sinensis 15～18g, Calculus Bovis 8～10g, Herba Asari 2～5g, Fructus Piperis Longi 12～14g, Herba Schizonepetae 12～14g, Fructus Carpesii 12～14g, Pericarpium Zanthoxyli 10～12g, Radix Saposhnikoviae 12～14g, Rhizoma Chuanxiong 12～14g, Radix Scrophulariae 12～14g, Rhizoma Cimicifugae 12～14g; aforementioned proportion Chinese medicine is ground into powder, made every capsule that contains 0.4-0.5 gram medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94115964A CN1060347C (en) | 1994-09-10 | 1994-09-10 | Capsule for eliminating pathogenic factor and alleviating pain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94115964A CN1060347C (en) | 1994-09-10 | 1994-09-10 | Capsule for eliminating pathogenic factor and alleviating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1118265A CN1118265A (en) | 1996-03-13 |
| CN1060347C true CN1060347C (en) | 2001-01-10 |
Family
ID=5037747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94115964A Expired - Fee Related CN1060347C (en) | 1994-09-10 | 1994-09-10 | Capsule for eliminating pathogenic factor and alleviating pain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1060347C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056080C (en) * | 1997-01-10 | 2000-09-06 | 枟现印 | Chinese medicine for curing trigeminal neuralgia and its preparation process |
| CN105853574A (en) * | 2016-04-18 | 2016-08-17 | 李国玉 | Pharmaceutical preparation for treating primary prosopalgia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1050683A (en) * | 1990-10-11 | 1991-04-17 | 张化文 | A kind of specific medicine for neuralgia, arthralgia, poliomyelitis sequel |
| CN1069411A (en) * | 1991-08-10 | 1993-03-03 | 范建宇 | Preparation method of sciatic nerve panaea |
-
1994
- 1994-09-10 CN CN94115964A patent/CN1060347C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1050683A (en) * | 1990-10-11 | 1991-04-17 | 张化文 | A kind of specific medicine for neuralgia, arthralgia, poliomyelitis sequel |
| CN1069411A (en) * | 1991-08-10 | 1993-03-03 | 范建宇 | Preparation method of sciatic nerve panaea |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1118265A (en) | 1996-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101559204A (en) | Traditional Chinese medicine compound treating irregular menstruation and dysmenorrheal and application thereof in preparing hygienic products of women | |
| CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
| CN104784511A (en) | Medicine for treating coronary heart disease | |
| CN1326550C (en) | Quick acting analgetic Chinese medicine liquid | |
| CN1060347C (en) | Capsule for eliminating pathogenic factor and alleviating pain | |
| CN103768275A (en) | Traditional Chinese medicinal hair growing fluid for treating alopecia seborrhoeica | |
| CN105617042A (en) | Traditional Chinese medicine composition for treating headache | |
| CN105287949A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN105477330A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN101195002B (en) | Chinese medicine emplastrum for releasing ache and health care | |
| CN1814218A (en) | Hormone external-dressing agent for treating dermatitis | |
| CN100348234C (en) | Externally applied ointment for treating mammary glands hyperplasia | |
| CN104435582A (en) | Traditional Chinese medicine plaster for treating depression and insomnia of middle-aged and old people | |
| CN103356962B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN101983645A (en) | Medicament for treating acute appendicitis | |
| CN1075726C (en) | Oral liquid for treatment of heart disease and its prepn. method | |
| CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
| CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
| CN102614479A (en) | Traditional Chinese medicine lotion preparation method for curing kidney-yang deficiency ecthyma | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101229255A (en) | Chinese traditional medicine formulation for treating acute waist injury | |
| CN105920541A (en) | Traditional Chinese medicinal composition for treating tinea versicolor | |
| CN105250856A (en) | Chinese herb composition for treating climacteric syndrome | |
| CN1943669A (en) | The Chinese traditional medicinal preparation for treatment of calculus | |
| CN105250956A (en) | Chinese herb composition for treating colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |